Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com95d agoneutral
Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ...BioPharma Dive95d agoneutral
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchGuruFocus.com95d agoneutral
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV ...The Wall Street Journal96d agoneutral
Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift RevenueBarrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryInvestor's Business Daily96d agobearish
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-UpInvestor's Business Daily114d agoneutral
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.The Wall Street Journal137d agoneutral
New Drugs Are Replacing Chemo for Aggressive Breast Cancer